Thyroid Disease and Lipids
Top Cited Papers
- 1 April 2002
- journal article
- review article
- Published by SAGE Publications in Thyroid®
- Vol. 12 (4) , 287-293
Abstract
The composition and the transport of lipoproteins are seriously disturbed in thyroid diseases. Overt hypothyroidism is characterized by hypercholesterolaemia and a marked increase in low-density lipoproteins (LDL) and apolipoprotein B (apo A) because of a decreased fractional clearance of LDL by a reduced number of LDL receptors in the liver. The high-density lipoprotein (HDL) levels are normal or even elevated in severe hypothyroidism because of decreased activity of cholesteryl-ester transfer protein (CETP) and hepatic lipase (HL), which are enzymes regulated by thyroid hormones. The low activity of CETP, and more specifically of HL, results in reduced transport of cholesteryl esters from HDL2 to very low-density lipoproteins (VLDL) and intermediate low-density lipoprotein (IDL), and reduced transport of HDL2 to HDL3. Moreover, hypothyroidism increases the oxidation of plasma cholesterol mainly because of an altered pattern of binding and to the increased levels of cholesterol, which presents a substrate for the oxidative stress. Cardiac oxygen consumption is reduced in hypothyroidism. This reduction is associated with increased peripheral resistance and reduced contractility. Hypothyroidism is often accompanied by diastolic hypertension that, in conjunction with the dyslipidemia, may promote atherosclerosis. However, thyroxine therapy, in a thyrotropin (TSH)-suppressive dose, usually leads to a considerable improvement of the lipid profile. The changes in lipoproteins are correlated with changes in free thyroxine (FT4) levels. Hyperthyroidism exhibits an enhanced excretion of cholesterol and an increased turnover of LDL resulting in a decrease of total and LDL cholesterol, whereas HDL are decreased or not affected. The action of thyroid hormone on Lp(a) lipoprotein is still debated, because both decrease or no changes have been reported. The discrepancies are mostly because of genetic polymorphism of apo(a) and to the differences between the various study groups. Subclinical hypothyroidism (SH) is associated with lipid disorders that are characterized by normal or slightly elevated total cholesterol levels, increased LDL, and lower HDL. Moreover, SH has been associated with endothelium dysfunction, aortic atherosclerosis, and myocardial infarction. Lipid disorders exhibit great individual variability. Nevertheless, they might be a link, although it has not been proved, between SH and atherosclerosis.Keywords
This publication has 65 references indexed in Scilit:
- Effects of Triiodothyronine and Amiodarone on the Promoter of the Human LDL Receptor GeneBiochemical and Biophysical Research Communications, 1998
- Both Hypothyroidism and Hyperthyroidism Enhance Low Density Lipoprotein OxidationThe Journal of Clinical Endocrinology & Metabolism, 1997
- Thyroid hormone therapy in cardiovascular diseaseProgress in Cardiovascular Diseases, 1996
- Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studiesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Lipoprotein-thyroid hormone interactionsTrends in Endocrinology & Metabolism, 1993
- Thyroxine replacement therapy and circulating lipid concentrationsClinical Endocrinology, 1993
- Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjectsThe Journal of Clinical Endocrinology & Metabolism, 1993
- Thyroid hormone action on intermediary metabolismJournal of Molecular Medicine, 1984
- Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein‐lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapyEuropean Journal of Clinical Investigation, 1981
- Effect of the Thyroid State on Myocardial Contractility and Ventricular Ejection Rate in ManCirculation, 1968